cbdMD (YCBD) EPS (Basic) (QoQ) (2017 - 2025)
cbdMD (YCBD) EPS (Basic) (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 78.67% |
| Sep 30, 2025 | 20.44% |
| Jun 30, 2025 | 88.83% |
| Mar 31, 2025 | -9.88% |
| Dec 31, 2024 | 19.19% |
| Sep 30, 2024 | -77.99% |
| Jun 30, 2024 | 88.89% |
| Mar 31, 2024 | -100.85% |
| Dec 31, 2023 | 91.92% |
| Sep 30, 2023 | -616.63% |
| Jun 30, 2023 | 32.96% |
| Mar 31, 2023 | 53.00% |
| Dec 31, 2022 | 68.61% |
| Sep 30, 2022 | 52.45% |
| Jun 30, 2022 | -473.42% |
| Mar 31, 2022 | 72.48% |
| Dec 31, 2021 | -339.32% |
| Sep 30, 2021 | -560.39% |
| Jun 30, 2021 | 107.05% |
| Mar 31, 2021 | -34.20% |